The impact of central sensitization-related symptoms on subacromial steroid injection outcomes in patients with subacromial impingement syndrome: an observational study.

IF 3.4 3区 医学 Q2 CLINICAL NEUROLOGY Korean Journal of Pain Pub Date : 2025-01-01 Epub Date: 2024-12-23 DOI:10.3344/kjp.24290
Feyza Nur Yücel, Semiha Özgüç, Yeliz Bahar-Özdemir, Emre Ata
{"title":"The impact of central sensitization-related symptoms on subacromial steroid injection outcomes in patients with subacromial impingement syndrome: an observational study.","authors":"Feyza Nur Yücel, Semiha Özgüç, Yeliz Bahar-Özdemir, Emre Ata","doi":"10.3344/kjp.24290","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Evidence indicates that central sensitization (CS) plays a role in subacromial impingement syndrome (SIS). Reduced treatment response has been associated with pretreatment pain sensitization features, such as CSrelated symptoms.</p><p><strong>Methods: </strong>Patients who received subacromial steroid injection were evaluated before the injection, at the first and third months. CS-related symptoms were investigated through the central sensitization inventory (CSI), and pain hypersensitivity was investigated by pressure pain threshold (PPT). Patients were evaluated using the visual analog scale (VAS), Quick Disabilities of the Arm, Shoulder, and Hand, Hospital Anxiety and Depression Scale, and Short Form-36.</p><p><strong>Results: </strong>With the injection, all participants had a significant reduction in shoulder pain (<i>P</i> < 0.05). In all follow-ups, VAS values did not differ significantly between the groups, and patients with CSI ≥ 40 had higher levels of disability, anxiety, depression, and worse quality of life before treatment (<i>P</i> < 0.05). Post-injection disability decreased significantly in the CS group and reached similar levels in both groups at the third month (<i>P</i> > 0.05). Although both groups' PPT values were comparable pre-treatment and at the third month, the CS group's affected shoulder showed a notable PPT decline at the first month (<i>P</i> < 0.05).</p><p><strong>Conclusions: </strong>Pre-treatment CS-related symptoms had no effect on SIS patients' responsiveness to steroid injections.</p>","PeriodicalId":56252,"journal":{"name":"Korean Journal of Pain","volume":" ","pages":"29-42"},"PeriodicalIF":3.4000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695246/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Korean Journal of Pain","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3344/kjp.24290","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Evidence indicates that central sensitization (CS) plays a role in subacromial impingement syndrome (SIS). Reduced treatment response has been associated with pretreatment pain sensitization features, such as CSrelated symptoms.

Methods: Patients who received subacromial steroid injection were evaluated before the injection, at the first and third months. CS-related symptoms were investigated through the central sensitization inventory (CSI), and pain hypersensitivity was investigated by pressure pain threshold (PPT). Patients were evaluated using the visual analog scale (VAS), Quick Disabilities of the Arm, Shoulder, and Hand, Hospital Anxiety and Depression Scale, and Short Form-36.

Results: With the injection, all participants had a significant reduction in shoulder pain (P < 0.05). In all follow-ups, VAS values did not differ significantly between the groups, and patients with CSI ≥ 40 had higher levels of disability, anxiety, depression, and worse quality of life before treatment (P < 0.05). Post-injection disability decreased significantly in the CS group and reached similar levels in both groups at the third month (P > 0.05). Although both groups' PPT values were comparable pre-treatment and at the third month, the CS group's affected shoulder showed a notable PPT decline at the first month (P < 0.05).

Conclusions: Pre-treatment CS-related symptoms had no effect on SIS patients' responsiveness to steroid injections.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
中枢致敏相关症状对肩峰下撞击综合征患者肩峰下类固醇注射结果的影响:一项观察性研究
背景:有证据表明中枢致敏(CS)在肩峰下撞击综合征(SIS)中起作用。治疗反应降低与预处理疼痛致敏特征有关,如cs相关症状。方法:对接受肩峰下类固醇注射的患者在注射前、第1个月和第3个月进行评估。通过中枢致敏量表(CSI)调查cs相关症状,通过压痛阈(PPT)调查疼痛超敏反应。采用视觉模拟量表(VAS)、手臂、肩膀和手的快速残疾、医院焦虑和抑郁量表以及Short Form-36对患者进行评估。结果:注射后,所有参与者肩痛均明显减轻(P < 0.05)。在所有随访中,各组间VAS值无显著差异,CSI≥40的患者治疗前残疾、焦虑、抑郁水平较高,生活质量较差(P < 0.05)。CS组注射后致残率明显降低,在第3个月时两组达到相近水平(P < 0.05)。虽然两组的PPT值在治疗前和第3个月相当,但CS组患肩PPT在第1个月明显下降(P < 0.05)。结论:治疗前cs相关症状对SIS患者对类固醇注射的反应性无影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Korean Journal of Pain
Korean Journal of Pain Medicine-Anesthesiology and Pain Medicine
CiteScore
5.40
自引率
7.10%
发文量
57
审稿时长
16 weeks
期刊介绍: Korean Journal of Pain (Korean J Pain, KJP) is the official journal of the Korean Pain Society, founded in 1986. It has been published since 1988. It publishes peer reviewed original articles related to all aspects of pain, including clinical and basic research, patient care, education, and health policy. It has been published quarterly in English since 2009 (on the first day of January, April, July, and October). In addition, it has also become the official journal of the International Spinal Pain Society since 2016. The mission of the Journal is to improve the care of patients in pain by providing a forum for clinical researchers, basic scientists, clinicians, and other health professionals. The circulation number per issue is 50.
期刊最新文献
Bone marrow mesenchymal stem cells improve bone cancer pain by inhibiting p38MAPK phosphorylation and microglia activation. Causal association of obesity and chronic pain mediated by educational attainment and smoking: a mediation Mendelian randomization study. Retraction: Comparison of the efficacy of genicular nerve phenol neurolysis and radiofrequency ablation for pain management in patients with knee osteoarthritis. Ultrasound-guided pain management: pros, cons, and benefits for the Philippines. Temporal therapy utilizing exosomes derived from M2 macrophages demonstrates enhanced efficacy in alleviating neuropathic pain in diabetic rats.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1